Acute pandysautonomia has been suggested to be an uncommon variant of Guillain-Barre' syndrome. Acute pandysautonomia does not seem to have been treated with intravenous immunoglobulin or other therapies proved efficacious in Guillain-Barre syndrome. A patient is reported with severe acute pandysautonomia who responded dramatically to intravenous immunoglobulin. The findings are consistent with a dysinmmune pathogenesis for this syndrome and suggest a possible treatment for future cases.
Acute pandysautonomia was first described by Young et al in 1969 .1 Since this time, 27 cases have been reported. The disorder presents with clinical features reminiscent of the autonomic failure of severe Guillain-Barre syndrome, including severe orthostasis, impairment of gastrointestinal motility and bladder function, impotence, impairment of pupillary reactivity and accommodation, and dryness of the eyes, nasopharynx, and skin. [25] [26] [27] Recovery occurs slowly and is often incomplete. Commonly, patients are left with disabling residual symptoms.8 13 15 17 19 24 Similarity between acute pandysautonomia and the autonomic failure of severe GuillainBarre syndrome suggests that acute pandysautonomia may be an uncommon variant of Guillain-Barre syndrome.1 3 4 24 Thomashefsky et al 19722" 24 24 (but temporary improvement with daily L-DOPS Ushiyama et al 199621 25 24 Wichser et al 197222 26 6 Yahr 
